C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema.
about
The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157:H7 to host cellsComplement inhibitors to treat IgM-mediated autoimmune hemolysisInhibition of Plasma Kallikrein by a Highly Specific Active Site Blocking AntibodyInhibition of classical complement activation attenuates liver ischaemia and reperfusion injury in a rat modelGene expression profiling of naïve sheep genetically resistant and susceptible to gastrointestinal nematodes.Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis.Discovery and Structural Modification of 1-Phenyl-3-(1-phenylethyl)urea Derivatives as Inhibitors of Complement.N-linked glycosylation at Asn3 and the positively charged residues within the amino-terminal domain of the c1 inhibitor are required for interaction of the C1 Inhibitor with Salmonella enterica serovar typhimurium lipopolysaccharide and lipid A.Potential therapeutic benefit of C1-esterase inhibitor in neuromyelitis optica evaluated in vitro and in an experimental rat modelC1-Inhibitor protects from focal brain trauma in a cortical cryolesion mice model by reducing thrombo-inflammationComplement-targeted therapeuticsSuccessful use of daily intravenous infusion of C1 esterase inhibitor concentrate in the treatment of a hereditary angioedema patient with ascites, hypovolemic shock, sepsis, renal and respiratory failure.Molecular and functional characterization of a ToxR-regulated lipoprotein from a clinical isolate of Aeromonas hydrophilaComplement and systemic lupus erythematosus.Conestat alfa (ruconest): first recombinant c1 esterase inhibitor for the treatment of acute attacks in patients with hereditary angioedema.The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1qAdministration of C1 inhibitor reduces neutrophil activation in patients with sepsisThe efficacy and safety of different anticoagulants on patients with severe sepsis and derangement of coagulation: a protocol for network meta-analysis of randomised controlled trials.Unmasking Heavily O-Glycosylated Serum Proteins Using Perchloric Acid: Identification of Serum Proteoglycan 4 and Protease C1 Inhibitor as Molecular Indicators for Screening of Breast Cancer.The effect of C1 inhibitor on myocardial ischemia and reperfusion injury.Human C1-Inhibitor Suppresses Malaria Parasite Invasion and Cytoadhesion via Binding to Parasite Glycosylphosphatidylinositol and Host Cell Receptors.Complement 1 inhibitor is a regulator of the alternative complement pathwayalpha(1)-Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1Serum concentrations of C reactive protein, alpha1 antitrypsin, and complement (C3, C4, C1 esterase inhibitor) before and during the Vuelta a EspańaN-linked glycosylation is required for c1 inhibitor-mediated protection from endotoxin shock in mice.The relationship between brachial ankle pulse wave velocity and complement 1 inhibitor.Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis.The effect of C1-esterase inhibitor on systemic inflammation in trauma patients with a femur fracture - The CAESAR study: study protocol for a randomized controlled trial.Anti-inflammatory effects of C1-Inhibitor in porcine and human whole blood are independent of its protease inhibition activity.Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7.Effect of the Anti-C1s Humanized Antibody TNT009 and Its Parental Mouse Variant TNT003 on HLA Antibody-Induced Complement Activation-A Preclinical In Vitro Study.Human plasma-derived C1 esterase inhibitor concentrate has limited effect on house dust mite-induced allergic lung inflammation in mice.Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica.Modulation of the complement system by human beta-defensin 2.C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood.Study of the effect of C1-esterase inhibitor administration to the sepsis pig model.Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.In vitro Inhibition of Canine Complement-Mediated Hemolysis.N- and O-glycosylation analysis of human C1-inhibitor reveals extensive mucin-type O-glycosylation.
P2860
Q24519797-47483377-1BA0-45FD-9B1A-93E5C40A9E51Q26777628-BCD1B24C-071F-41A7-A36C-7E36AE923016Q27684478-71AE334F-C374-4E4F-B10A-BD0BFA95F5A5Q28577389-29C23FBB-7DAA-4E69-9991-6B8B4B9CE461Q33235441-BE4F436D-84CC-437C-B7FA-C6DE791EEDD8Q33598636-F4FE647D-1955-4980-8177-DDD8339B0A39Q33630434-7341BB6B-70DD-4FF9-AC7C-DA4006776A4DQ33946526-9315EEA6-9FE1-430F-A2C7-6A1E8B051808Q34142474-8CDB4C98-DE14-48BF-9EA4-837A34A42CF3Q34154658-37A28C54-A5D1-4588-8CA5-E12AAA721B8EQ34255011-16602229-3350-4FA9-A2F4-1EF6BCE5AAD3Q34720987-F6C4C5DA-45E8-4A93-931F-E3D9CA713B4BQ34721131-AEBEEE0C-FF6D-4C13-97E5-404917258E5EQ34731255-8EDD9A7C-45DF-4870-A2E2-D88A686085C5Q35042407-B8B39D89-072D-4700-B2A8-59794AB45B51Q35098041-59830CA0-0794-4253-B134-F0A9975DBA0FQ35140175-F614B7BB-1D05-4C4D-BD42-C77D56FC1327Q35532746-0F50ACA2-D9BA-4F85-A85C-18C61B4B7A71Q35927365-1B717DCF-796F-4554-A707-5B4536AF17F1Q36253316-F16B8651-A047-4CA5-A887-C782B6C1D469Q36365306-952DB4F7-8F1B-4923-BBE3-F12FFB798B02Q36369674-6E4383A5-B242-4533-AF7F-FA3A54BAE802Q36639349-34C7D55D-69F6-491A-8D62-A55B070A3429Q36801753-BAEAD272-53EC-4D93-9468-1EDE389EEAEEQ37116328-14873972-5940-4F39-9383-8AA08DC9A1BFQ37364515-CEFDC659-DD47-45A3-A293-4CE195F7A2B1Q38042223-119AF655-B97D-4E94-9B1B-7145C1E32653Q38783936-528D923C-0746-4E7B-90AF-FDB3C3C32AEAQ41393053-D91B03F5-D47F-4BF3-A3EA-4D72DAD04119Q42068191-AF34C80B-9C62-4D22-83AA-5816C29DBCACQ42359412-8FDEB35C-7907-4AFB-9A33-7EA050C436DAQ42695895-FA7AD2D3-7AE7-45C4-8C4D-D9A4FFB7E96FQ42951267-8CE0F879-A9D1-44C2-AC08-D8C05ADB9CADQ43011755-99B60287-0BA8-4812-9E65-3D04223CBA8AQ44198286-CB56626A-B059-45EE-83DF-835307835C80Q46057314-9601EE9A-3D58-4862-95EE-6896DEDD1DE5Q47720411-271E0CCD-CD17-4A8F-A518-541BC89D2C7FQ48242958-89D5B501-4377-463F-A1BC-17D891337726Q49886884-C6A40C8F-3329-4B4E-84AA-3C83FCA4421B
P2860
C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
C1-Esterase inhibitor: an anti ...... er than hereditary angioedema.
@ast
C1-Esterase inhibitor: an anti ...... er than hereditary angioedema.
@en
type
label
C1-Esterase inhibitor: an anti ...... er than hereditary angioedema.
@ast
C1-Esterase inhibitor: an anti ...... er than hereditary angioedema.
@en
prefLabel
C1-Esterase inhibitor: an anti ...... er than hereditary angioedema.
@ast
C1-Esterase inhibitor: an anti ...... er than hereditary angioedema.
@en
P2093
P1476
C1-Esterase inhibitor: an anti ...... her than hereditary angioedema
@en
P2093
P304
P577
2000-03-01T00:00:00Z